The Effect of Early Application of Synthetic Peptides 19-2.5 and 19-4LF to Improve Survival and Neurological Outcome in a Mouse Model of Cardiac Arrest and Resuscitation

The synthetic antimicrobial peptides (sAMPs) Pep19-2.5 and Pep19-4LF have been shown in vitro and in vivo to reduce the release of pro-inflammatory cytokines, leading to the suppression of inflammation and immunomodulation. We hypothesized that intervention with Pep19-2.5 and Pep19-4LF immediately a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajorat, Rika, Danckert, Lena, Ebert, Florian, Bancken, Theresa, Bergt, Stefan, Klawitter, Felix, Vollmar, Brigitte, Reuter, Daniel A., Schürholz, Tobias, Ehler, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045145/
https://www.ncbi.nlm.nih.gov/pubmed/36979834
http://dx.doi.org/10.3390/biomedicines11030855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045145/
https://www.ncbi.nlm.nih.gov/pubmed/36979834
http://dx.doi.org/10.3390/biomedicines11030855

Ejemplares similares